Georgia Cancer Center Annual Symposium on Advances and Paradigm Shifts in Hematology/Oncology 2023

Describe advances in clinical genetic and molecular characteristics of various malignancies as they relate to pathophysiology, prognosis, and effective treatment strategies. Introduce new treatment paradigms in immunotherapy and CAR-T and cellular therapies. Review the integration of strategies for the rational and evidence-based combinations of surgery, chemotherapy, immunotherapy, targeted therapy, and radiotherapy as we design the optimal management of pulmonary, breast, genitourinary and gynecological tumors. Describe new immunotherapeutic approaches to those tumors with driver mutations and mismatch repair-deficient characteristics. Review advances in genitourinary and gynecologic oncology. Introduce advanced management of brain tumors and future opportunities for experimental therapeutics, such oncolytic viruses. Explore new findings in hereditary cancer and how they may relate to risks, approaches to cancer prevention, and early detection strategies..

Registration:

Physician - $200.00

Non-Physician - $100.00

1. Update our current immunotherapeutic strategies for cancer control with emphasis on Chimeric Antigen Receptor T Cell Therapy and promising additional Immunotherapy strategies.
2. Discuss paradigm shifts in medical oncology as they have been influenced by the discovery of targetable driver mutations and recent clinical trials.
3. Present the updated treatment guidelines for patients presenting with cancers of the head and neck, prostate, testis, ovary, lung, colon, brain and breast.
4. Review relevant translational research and related phase one clinical trials that hold promise in expanding current available treatment options.
5. Describe new surgical techniques that improve upon the diagnosis, staging, and resection of cancer, as well as speed recovery and favorably impact survival.
6. Present appropriate strategies for incorporating the new oral anti-coagulants for prophylaxis and treatment of thromboembolic disorders
7. Identify pertinent ongoing research in cancer treatment at GCC and elsewhere.

Cancellation Policy

The Medical College of Georgia reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
The Medical College of Georgia is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Hotel(s) offering your special group rate:
Marriott Savannah Riverfront for 269 USD - 369 USD per night

Book your group rate for Georgia Cancer Center Annual Symposium 2023

The Medical College of Georgia’s Office for Faculty & Continuous Professional Development adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Elizabeth D Jones, MSA
Department Administrator, Cancer Service Line
Medical College of Georgia at Augusta University
Augusta, GA

Activity Administrator

Nothing to disclose

Anand P Jillella, MD
Professor and Chief; Division of Hematology/Oncology Dept. of Medicine; Director of GCC Clinic, Ambulatory Services, Network and Outreach Georgia Cancer Center
Medical College of Georgia at Augusta University
Augusta, GA

Course Director, Faculty

Nothing to disclose

Hossein Borghaei, DO
Professor and Chief, Co-Director, Immune Monitoring Facility
Fox Chase Cancer Center
Philadelphia, PA

Faculty

Advisor-Bristol-Myers Squibb Company|Advisor-Lilly (Any division)|Advisor-Pfizer|Advisor-Merck (Any division)|Advisor-EMD Serono|Advisor-Boehringer Ingelheim Pharmaceuticals, Inc.|Advisor-AstraZeneca (Any division)|Advisor-Novartis Corporation Pharmaceuticals|Advisor-Genentech (Any division)|Advisor-Regeneron Pharmaceuticals, Inc.|Advisor-Amgen, Inc.|Consulting Fee-Pharmamar|Advisor-Takeda Pharmaceuticals (Any division)|Advisor-Mirati|Advisor-Daiichi Sankyo, Inc.|Advisor-Jazz Pharmaceuticals, Inc.|Advisor-Bayer (Any division)|Advisor-IOBiotech|Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Lilly (Any division)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis Corporation Pharmaceuticals|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Springworks|Membership on Advisory Committees or Review Panels, Board Membership, etc.-U of Penn|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Incyte Corporation Incyte Corporation|Stocks or stock options, excluding diversified mutual funds-Sonnetbio|Stocks or stock options, excluding diversified mutual funds-Inspirna|Stocks or stock options, excluding diversified mutual funds-Nucleai|Honoraria-Pfizer

Adam Brufsky, MD, PhD
Professor of Medicine, Associate Director for Clinical Investigation, Medical Director of the Magee-Women's Cancer Program
University of Pittsburg School of Medicine
Pittsburg, PA

Faculty

Advisor-AstraZeneca (Any division)|Advisor-Pfizer|Advisor-Lilly (Any division)|Advisor-Novartis Corporation Pharmaceuticals|Advisor-Lilly (Any division)|Advisor-Roche (Any division)|Advisor-Seattle Genetics, Inc.|Advisor-Daiichi Sankyo, Inc.|Advisor-Merck (Any division)|Advisor-Myriad (Any division)

Spero Cataland, MD
Professor of Medicine Director, Benign Hematology
Ohio State University, The James Comprehensive Cancer Center
Columbus, OH

Faculty

Consulting Fee-Sanofi S.A.

Abraham Cheong, MD
Attending Physician
Southeast Georgia Health System Cancer Center
Brunswick, GA

Faculty

Nothing to disclose

Jordan Ciuro, MD
Clinical Assistant Professor; Division of Hematology/Oncology, Department of Medicine; Member, Breast and GU Oncology Programs Georgia Cancer Center
Medical College of Georgia at Augusta University
Augusta, GA

Faculty

Nothing to disclose

Paul M Dainer, MD, Physician
Associate Professor of Medicine, Division of Hematology/Oncology
Medical College of Georgia at Augusta University
Augusta, GA

Faculty

Nothing to disclose

Aaron Flanders, MD
Attending Physician
Augusta Oncology Associates
Augusta, GA

Faculty

Nothing to disclose

Apar Kishor Ganti, MD
Doctor and Mrs. D. Leon UNMC Research Fund Chair in Internal Medicine; Staff Physician, VA Nebraska Western Iowa Health Care System; Professor of Medicine, Division of Oncology-Hematology; Professor (Courtesy) of Biochemistry and Molecular Biology; Associate Director of Clinical Research, Fred & Pamela Buffett Cancer Center
University of Nebraska Medical Center
Omaha, NE

Faculty

Advisor-Jazz Pharmaceuticals, Inc.|Honoraria-Cardinal Health|Grant or research support-Chimerx|Grant or research support-Merck (Any division)|Grant or research support-Mirati|Grant or research support-IOVANCE|Speakers Bureau-MJH Life Sciences

Sharad Anant M Ghamande, MD
Professor of Obstetrics and Gynecology; Chair, Dept. of Obstetrics and Gynecology, Medical College of Georgia; Associate Director for Clinical Research Georgia Cancer Center
Medical College of Georgia at Augusta University
Augusta, GA

Faculty

Speakers Bureau-Tesaro (Relationship has ended)

Stephanie Graff, MD
Associate Professor of Medicine, Director of Breast Oncology, Co-Leader, Breast Cancer Translational Research Disease Group
Warren Alpert Medical School, Brown University
Providence, RI

Faculty

Advisor-AstraZeneca (Any division) (Relationship has ended)|Advisor-Lilly (Any division) (Relationship has ended)|Advisor-Pfizer (Any division) (Relationship has ended)|Advisor-Daiichi Sankyo, Inc. (Relationship has ended)|Honoraria-MJH Life Sciences (Relationship has ended)|Advisor-Menarini (Relationship has ended)|Honoraria-Wolters Kluwer (Relationship has ended)|Advisor-Novartis Corporation Pharmaceuticals (Relationship has ended)|Advisor-Gilead Sciences, Inc. (Relationship has ended)

Avirup Guha, MD, MPH, FACC, FICOS, RPVI
Assistant Professor of Medicine; Division of Cardiology, Department of Medicine; Director of Cardio-Oncology Program Georgia Cancer Center
Medical College of Georgia at Augusta University
Augusta, GA

Faculty

Consulting Fee-Pfizer|Consulting Fee-Novartis Corporation Pharmaceuticals|Grant or research support-Sumitovant biopharma

Daniel Halperin, MD
Associate Professor
University of Texas MD Anderson Cancer Center Houston, Texas
Houston, TX

Faculty

Grant or research support-Novartis Corporation Pharmaceuticals|Grant or research support-ITM|Grant or research support-Camurus|Grant or research support-RayzeBio|Grant or research support-ThermoFisher Scientific|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AlphaMedix

John Henson, MD
Professor of Neurology; Department of Neurology, Medical College of Georgia; Director, Neuro-Oncology Program Georgia Cancer Center
Medical College of Georgia at Augusta University
Augusta, GA

Faculty

Nothing to disclose

Shaheen Islam, MD
Professor of Medicine & Surgery Chief, Division of Pulmonary, Critical Care & Sleep Medicine Director, Interventional Pulmonology
Medical College of Georgia at Augusta University
Augusta, GA

Faculty

Consulting Fee-Cook Medical, Inc. (Relationship has ended)

Ravindra Kolhe, MD, PhD, Physician
Professor of Pathology; Interim Chair, Department of Pathology; Medical Director of Cytogenetics Laboratory at AU Medical Center; Director, Georgia Esoteric & Molecular Laboratory
Medical College of Georgia at Augusta University
Augusta, GA

Faculty

Grant or research support-Illumina, Agena, QIAGEN, Perkin Elmer, Bionano, PGDx ( Lab Corp), One Cell Dx, |Consulting Fee-Agena, Perkin Elmer, Bionano, Cepheid, Novartis, AbbVie, and AstraZeneca

Vamsi Kota, MD
Professor of Medicine; Director, Bone Marrow Transplant Program, Division of Hematology/Oncology Department of Medicine Georgia Cancer Center
Medical College of Georgia at Augusta University
Augusta, GA

Faculty

Grant or research support-Incyte Corporation Incyte Corporation|Advisor-Pfizer (Any division)|Advisor-Novartis Corporation Pharmaceuticals|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Takeda Pharmaceuticals (Any division)

Robert Krywicki, MD
Phoebe Putney Cancer Center
Albany, GA

Faculty

Nothing to disclose

Daniel L Miller, MD
Professor of Surgery; Director, Thoracic Surgery, Department of Surgery
Medical College of Georgia at Augusta University
Augusta, GA

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Johnson & Johnson|Speakers Bureau-Acumed, Inc|Speakers Bureau-Tela Bio, Inc |Speakers Bureau-Atricure, Inc

Asha Nayak, MD
Professor of Medicine; Division of Hematology/Oncology, Department of Medicine; Co-Leader, GI Oncology Program; Director, Inpatient Unit, Medicine-Hematology/Oncology Georgia Cancer Center
Medical College of Georgia at Augusta Univeristy
Evans, GA

Faculty

Nothing to disclose

Girindra Raval, MD
Assistant Professor of Medicine Associate Director, Hem/Onc Fellowship Program Associate Director, Center for Blood Disorders
Medical College of Georgia at Augusta University
Augusta , GA

Faculty

Nothing to disclose

Priyanka Raval, MD
Assistant Professor of Medicine Co-Leader, Breast Oncology Program
Medical College of Georgia at Augusta University
Augusta, GA

Faculty

Nothing to disclose

Bunja Rungruang, MD
Professor and Chief Section of Gynecologic Oncology
Medical College of Georgia at Augusta University
Augusta, GA

Faculty

Nothing to disclose

Apurva Shah, MD
Attending Physician
Anita Stewart Oncology Center
Tifton, GA

Faculty

Nothing to disclose

Martha K Terris, MD, FACS
Professor and Chair, Department of Urology
Medical College of Georgia at Augusta University
Augusta, GA

Faculty

Nothing to disclose

Gerald C Wallace IV, MD
Assistant Professor Neurology, Neuro-Oncology
Medical College of Georgia at Augusta University
Augusta, GA

Faculty

Nothing to disclose

Marcus Weldon, MD
Attending Physician
Central Georgia Cancer Center
Macon, GA

Faculty

Nothing to disclose

Gustavo Westin, MD
Attending Physician
University Cancer and Blood Center
Athens, GA

Faculty

Nothing to disclose

Danny Yakoub, MD, PhD, FACS
Associate Professor of Surgery, Surgical Oncology
Medical College of Georgia at Augusta University
Augusta, GA

Faculty

Nothing to disclose

Mohammad Mian, PhD
Manager, Bone Marrow Transplant Program
Medical College of Georgia at Augusta University
Augusta, GA

Other Planning Committee Member

Nothing to disclose

Tyra Newton, NP
Lead APP, Cancer Service Line
Medical College of Georgia at Augusta University
Augusta, GA

Other Planning Committee Member

Nothing to disclose